Our team

Our Chairman and Board

Neil Butler
Neil is an IVD specialist with over 20 years’ experience managing global medical diagnostic companies.
Neil serves on the Board of Nidor Dx, Radisens and Spectromics and was previously Chair and Non-Executive Director for Atlas Genetics / Binx Health and Genomic Vision.

Professor Sir John Burn
Vice Chair
Sir John is Chairman of the Newcastle upon Tyne Hospitals NHS Foundation Trust, Professor of Clinical Genetics at Newcastle University, led the regional NHS Genetics Service for 20 years and helped to create the International Centre for Life.

Nigel Williams
Non Executive Director
Nigel is the former CEO of Barclays Global Investors – Europe & Asia. As one of QuantuMDx’s earliest investors, Nigel has played a key role in supporting the management team in navigating the challenges of operating as a start-up.

Dr Mirre de Noo
Non Executive Director
Mirre has over 20 years of experience in healthcare, strategy and innovation.
Currently, Mirre is the Chief Executive Officer of Reggeborgh Medical and a Consultant Surgeon at Xpert Clinics, a private specialist medical service provider with 30 locations across the Netherlands.

Tony Tan
Non Executive Director
As one of QuantuMDx’s earliest investors, Tony has played a key role in supporting the management team, providing key strategic advice and guidance.

Elaine Warburton
Non Executive Director
Elaine is the co-founder and former CEO of QuantuMDx. She is an entrepreneur with over 30 years’ healthcare and biotechnology experience.
Elaine took QuantuMDx from concept to product, raising over £50m in both equity and grants. Elaine has raised over £100m in funding as an entrepreneur and was awarded an OBE for services to innovation in healthcare in 2014.

Jonathan O’Halloran
Jonathan is Co-Founder of QuantuMDx, former Chief Scientific Officer and inventor of many of its proprietary technologies.
He has a specialist interest in AMR and was a diagnostics advisor for the O’Neill Review.  Jonathan was awarded European CTO of the Year in 2015.

Our Senior Leadership Team

Diran Guiliguian
Diran has over a decade of experience working within world-leading diagnostic and medical device companies.
Most recently he was Head of Central Lab Solutions for EMEA at Siemens Healthineers where he led the introduction of the company’s COVID-19 testing.

Justine Ladd
VP Finance
Justine is a Big Four qualified FCA with 25 years’ finance experience from start-ups/SMEs through to FTSE 100, including managing the FP&A and Financial Reporting teams at Sage.

Marie Whitehouse
VP Operations
With over 10 years’ experience in operations management, Marie has played an integral role in the growth and development of the company.
She oversees corporate services, HR, IT, facilities, procurement and supply chain management at QuantuMDx.

Colin Toombs
Colin is a global R&D technology leader with over 30 years’ experience in both product and process development. He has worked across a range of industries – including pharmaceuticals and life sciences – for ThermoFisher, Teva, and helped develop the Biocartis and Enigma Diagnostics point of care systems.
He has worked across a range of industries – including pharmaceuticals and life sciences – for Thermo Fisher, Tevo, Biocartis and Enigma.

Andy Whittle
VP Manufacturing
Andy is a specialist in global operations and manufacturing with over 20 years’ experience leading teams to establish and optimise manufacturing at ThermoFisher, Novartis, Vivacta and Jupiter Diagnostics

Caroline Alexander
VP Quality & Regulatory Affairs
Caroline is an experienced Quality and Regulatory Affairs professional with a proven track record in designing, implementing and maintaining excellent quality management systems across a number of healthcare-related industries.
Caroline has over 10 years’ experience specifically in the In Vitro Diagnostic medical devices sector.

Robin Page
VP Systems Integration
Robin is a specialist in biosensor technologies with over 18 years’ experience working in academia and industry.
Robin has in-depth experience of molecular biology and surface chemistry and currently leads our project management team.

Jonathan Peat
Business Development
Jonathan is a life science industry expert with over 20 years of experience within the sector, 14 years within the commercial space. Specialising in grant funding, opportunity identification, stakeholder engagement, strategy and commercial planning/rollout.